NEOG250117C7500
- 9.43
- 0.000.00%
Neogen Newsroom
Neogen Price Target Cut to $13.00/Share From $16.50 by Piper Sandler
Piper Sandler Reiterates Neutral on Neogen, Lowers Price Target to $13
Neogen Analyst Ratings
Neogen Introduces Igenity BCHF to Help Industry Mitigate Bovine Congestive Heart Failure Risk
Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Cuts Target Price to $13
Piper Sandler Keeps Their Hold Rating on Neogen (NEOG)
Insider Purchase: CEO of $NEOG (NEOG) Buys 23,035 Shares
Anticoagulant Rodenticides Market Trends Analysis Report 2025-2030, Featuring BASF, Bayer, Syngenta, PelGar, Rentokil, UPL, Bell Labs, Kalyani Industries, Heranba Industries, Neogen and Liphatech
Express News | Neogen® Launches New MDA2 Quantitative Salmonella Molecular Detection Assay
Neogen Launches New MDA2 Quantitative Salmonella Molecular Detection Assay
Neogen | 10-Q: Q2 2025 Earnings Report
Express News | NeoGenomics Shares Are Trading Higher Following Strong FY25 Guidance
Neogen Corp (NEOG) Q2 2025 Earnings Call Highlights: Navigating Challenges With Strategic ...
Express News | Neogen Corp -Expects to Record an Impairment Charge of $461.4 Million in Q2 FY25
Express News | Neogen Corp Files for Non- Timely 10-Q With U.S. SEC
Sector Update: Health Care Stocks Decline Premarket Friday
Neogen Shares Are Trading Lower After the Company Issued FY25 Revenue Guidance Below Estimates.
Neogen's Preliminary Fiscal Q2 Adjusted Earnings Unchanged, Revenue Increases; Fiscal 2025 Sales Outlook Lowered
Neogen (NEOG) Q2 Earnings Match Estimates
Neogen: Fiscal Q2 Earnings Snapshot